NCT01949441View on ClinicalTrials.gov

ToleroMune House Dust Mite (HDM) Tolerability Study

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Rhinoconjunctivitis
Interventions
BIOLOGICAL

ToleroMune HDM

Intradermal injection 1 x 4 administrations 4 weeks apart

BIOLOGICAL

Placebo

Intradermal injection 1 x 4 administrations 4 weeks apart

Trial Locations (1)

M9C 4Z5

Topstone Research, Toronto

Sponsors

Collaborators (1)

Adiga Life Sciences, Inc.
All Listed Sponsors
collaborator

Adiga Life Sciences, Inc.

INDUSTRY

lead

Circassia Limited

INDUSTRY

NCT01949441 - ToleroMune House Dust Mite (HDM) Tolerability Study | Biotech Hunter | Biotech Hunter